Dysregulation of Placental Endothelial Lipase in Obese Women With Gestational Diabetes Mellitus
- Martin Gauster1⇓,
- Ursula Hiden2,
- Mireille van Poppel3,
- Sasa Frank4,
- Christian Wadsack2,
- Sylvie Hauguel-de Mouzon5 and
- Gernot Desoye2
- 1Institute of Cell Biology, Histology and Embryology, Center for Molecular Medicine, Medical University of Graz, Graz. Austria
- 2Department of Obstetrics and Gynecology, Medical University of Graz, Graz, Austria
- 3Department of Public and Occupational Health, EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, the Netherlands
- 4Institute of Biochemistry and Molecular Biology, Center for Molecular Medicine, Medical University of Graz, Graz, Austria
- 5Department of Reproductive Biology, Case Western Reserve University at MetroHealth Medical Center, Cleveland, Ohio
- Corresponding author: Martin Gauster, .
OBJECTIVE This study addressed the hypothesis that placental endothelial lipase (EL) expression is affected by pregnancies complicated by obesity and gestational diabetes mellitus (GDM).
RESEARCH DESIGN AND METHODS EL expression in placental tissues from pregnancies complicated by obesity, GDM, or obesity combined with GDM (obese-GDM) was analyzed by quantitative RT-PCR. Moreover, primary placental cells were isolated and treated with insulin, glucose, leptin, or tumor necrosis factor (TNF)-α, and EL expression was measured. Inhibitors of nuclear factor (NF)-κB or mitogen-activated protein kinase (MAPK) signaling were used to detect potential pathways of EL regulation in primary placental endothelial cells (ECs).
RESULTS In placentas from obese-GDM pregnancies, EL expression was upregulated by 1.9-fold (P < 0.05) compared with lean pregnancies, whereas obesity or GDM alone had no significant effect. Analyses of metabolic parameters in maternal venous and umbilical venous plasma revealed significantly increased insulin and leptin as well as slightly increased glucose and TNF-α values in the obese and obese-GDM groups. Cell culture experiments identified TNF-α and leptin, but not glucose or insulin, as regulators of EL expression in ECs. Induction of EL expression by these mediators occurred in a para/endocrine manner, since only leptin and TNF-α receptors, but not the cytokines themselves, were expressed in ECs. Inhibitor experiments suggested that TNF-α and leptin-mediated upregulation of EL may occur via two different routes. Whereas TNF-α induced EL upregulation in ECs by activation of the NF-κB pathway, leptin did not stimulate NF-κB or MAPK signaling pathways in these cells.
CONCLUSIONS Metabolic inflammation with high leptin and locally increased TNF-α concentrations at the fetal-placental interface regulates placental EL expression.
- Received October 8, 2010.
- Accepted July 8, 2011.
- © 2011 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.